Name: LENZ Therapeutics, Inc. (LENZ) Financial Statements
Creator: FinSpry

LENZ Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

LENZ Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.00	0.00	15.00	0.00
Cost of Revenue	0.06	0.00	0.00	0.00
Gross Profit	-0.06	0.00	15.00	0.00
Operating Expenses
Research & Development	29.80	59.50	21.13	4.22
Selling, General & Administrative	28.75	12.93	4.36	2.47
Operating Expenses	58.55	72.43	25.48	6.69
Operating Income	-58.61	-72.43	-10.48	-6.69
Other Income/Expense
Interest Income	8.55	2.19	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00
Other Income/Expense	8.84	0.09	0.02	-0.87
Income
Income Before Tax	-49.77	-70.15	-10.46	-7.56
Income Tax Expense	0.00	-0.18	0.35	0.00
Net Income	-49.77	-69.97	-10.81	-7.56
Net Income - Continuous Operations	-49.77	-69.97	-10.81	-7.56
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-49.71	-72.41	-10.48	-6.69
EBIT	-49.77	-72.43	-10.48	-6.69
Depreciation & Amortization	0.06	0.02	0.01	0.00
Earnings Per Share
Basic EPS	-2.00	-36.00	-	-1.00
Diluted EPS	-2.00	-36.00	-	-1.00
Basic Shares Outstanding	21.28	1.96	25.53	9.36
Diluted Shares Outstanding	21.28	1.96	25.53	9.36